Prescription ID | TCMF2108 |
Pinyin Name | Wei Qi Shuang Jie Tang |
Chinese Name | |
English Name | Qi Protection Double Solution Decoction |
Function Description | |
Indications | None |
Disease ICD-11 Category | |
Human Tissues Associated with Indication | |
Reference | Chinese Classical Prescriptions |
Reference Book/link | ISBN 7-5023-3930-2 |
Component ID | Latin Name | Chinese Name | Component Quantity | Barcode |
---|---|---|---|---|
TCMH1665 | Notopterygium incisum | 羌活 | TCMH1665 | JF755946 |
TCMH78 | Platycodon grandiflorum | 白桔梗 | TCMH78 | ITSAJ4293-14 |
TCMH2442 | Radix rumicis japonici | 羊蹄根 | TCMH2442 | |
TCMH127 | Isatis indigotica | 板蓝根 | TCMH127 | KJ765825 |
TCMH1652 | Paris polyphylla | 七叶一枝花 | TCMH1652 | ITSAH2421-14 |
TCMH986 | Scutellaria baicalensis | 黄芩 | TCMH986 | ITSAP4211-14 |
TCMH1931 | Gypsum fibrosum | 石膏 | TCMH1931 | |
TCMH805 | Calcitum | 寒水石 | TCMH805 | |
TCMH628 | Glycyrrhiza uralensis | 甘草 | TCMH628 | ITSAM892-14 |
Target ID | Gene Symbol | Target Name | Target Class | Uniprot ID |
---|---|---|---|---|
TCMT101 | PTPN1 | Protein-tyrosine phosphatase 1B | Hydrolase | P18031 |
TCMT112 | ADORA3 | Adenosine A3 receptor | GPCR | P0DMS8 |
TCMT127 | PARP1 | Poly [ADP-ribose] polymerase-1 | Transferase | P09874 |
TCMT128 | TNKS2 | Tankyrase-2 | Transferase | Q9H2K2 |
TCMT129 | TNKS | Tankyrase-1 | Transferase | O95271 |
TCMT130 | ALOX5 | Arachidonate 5-lipoxygenase | Oxidoreductase | P09917 |
TCMT131 | ACHE | Acetylcholinesterase | Hydrolase | P22303 |
TCMT133 | CA1 | Carbonic anhydrase I | Lyase | P00915 |
TCMT134 | CA2 | Carbonic anhydrase II | Lyase | P00918 |
TCMT135 | CA14 | Carbonic anhydrase XIV | Lyase | Q9ULX7 |
TCMT136 | CA12 | Carbonic anhydrase XII | Lyase | O43570 |
TCMT137 | CA9 | Carbonic anhydrase IX | Lyase | Q16790 |
TCMT138 | CA7 | Carbonic anhydrase VII | Lyase | P43166 |
TCMT142 | CA4 | Carbonic anhydrase IV | Lyase | P22748 |
TCMT156 | CYP19A1 | Cytochrome P450 19A1 | Oxidoreductase | P11511 |
TCMT159 | TYR | Tyrosinase | Oxidoreductase | P14679 |
TCMT162 | UGT1A1 | UDP-glucuronosyltransferase 1-1 | Transferase | P22309 |
TCMT174 | HSD11B1 | 11-beta-hydroxysteroid dehydrogenase 1 | Oxidoreductase | P28845 |
TCMT188 | DHFR | Dihydrofolate reductase | Oxidoreductase | P00374 |
TCMT190 | PTPN2 | T-cell protein-tyrosine phosphatase | Hydrolase | P17706 |
TCMT209 | HSD11B2 | 11-beta-hydroxysteroid dehydrogenase 2 | Oxidoreductase | P80365 |
TCMT215 | CYP1A1 | Cytochrome P450 1A1 | Oxidoreductase | P04798 |
TCMT219 | CYP1A2 | Cytochrome P450 1A2 | Oxidoreductase | P05177 |
TCMT223 | AKR1B1 | Aldose reductase | Oxidoreductase | P15121 |
TCMT23 | ALPL | Alkaline phosphatase, tissue-nonspecific isozyme | Hydrolase | P05186 |
TCMT231 | GBA2 | Beta-glucosidase | Hydrolase | Q9HCG7 |
TCMT232 | ABCB1 | P-glycoprotein 1 | Transporter | P08183 |
TCMT236 | ESR2 | Estrogen receptor beta | Nuclear receptor | Q92731 |
TCMT240 | AMY1A | Salivary alpha-amylase | Unclassified | P04745 |
TCMT249 | CDK6 | Cyclin-dependent kinase 6 | Kinase | Q00534 |
TCMT254 | CBR1 | Carbonyl reductase [NADPH] 1 | Oxidoreductase | P16152 |
TCMT257 | CYP1B1 | Cytochrome P450 1B1 | Oxidoreductase | Q16678 |
TCMT261 | DAPK1 | Death-associated protein kinase 1 | Kinase | P53355 |
TCMT265 | GSK3B | Glycogen synthase kinase-3 beta | Kinase | P49841 |
TCMT280 | AKR1B10 | Aldo-keto reductase family 1 member B10 | Oxidoreductase | O60218 |
TCMT283 | PTPRS | Receptor-type tyrosine-protein phosphatase S | Hydrolase | Q13332 |
TCMT296 | ADORA1 | Adenosine A1 receptor | GPCR | P30542 |
TCMT297 | FABP4 | Fatty acid binding protein adipocyte | Unclassified | P15090 |
TCMT298 | FABP3 | Fatty acid binding protein muscle | Hydrolase | P05413 |
TCMT3 | ALOX15 | Arachidonate 15-lipoxygenase | Oxidoreductase | P16050 |
TCMT30 | PTGS2 | Cyclooxygenase-2 | Oxidoreductase | P35354 |
TCMT318 | HKDC1 | Putative hexokinase HKDC1 | Transferase | Q2TB90 |
TCMT336 | IDO1 | Indoleamine 2,3-dioxygenase | Oxidoreductase | P14902 |
TCMT337 | XPO1 | Exportin-1 | Unclassified | O14980 |
TCMT344 | AOX1 | Aldehyde oxidase | Oxidoreductase | Q06278 |
TCMT384 | GRK6 | G protein-coupled receptor kinase 6 | Kinase | P43250 |
TCMT46 | F3 | Coagulation factor III | Unclassified | P13726 |
TCMT47 | BCL2 | Apoptosis regulator Bcl-2 | Ion channel | P10415 |
TCMT506 | PTK2B | Protein tyrosine kinase 2 beta | Kinase | Q14289 |
TCMT563 | CDC25B | Dual specificity phosphatase Cdc25B | Hydrolase | P30305 |
TCMT591 | ESRRA | Estrogen-related receptor alpha | Nuclear receptor | P11474 |
TCMT592 | XDH | Xanthine dehydrogenase | Oxidoreductase | P47989 |
TCMT597 | SLC28A3 | Solute carrier family 28 member 3 | Transporter | Q9HAS3 |
TCMT63 | PPARA | Peroxisome proliferator-activated receptor alpha | Nuclear receptor | Q07869 |
TCMT65 | HSD17B1 | Estradiol 17-beta-dehydrogenase 1 | Oxidoreductase | P14061 |
TCMT66 | HSD17B2 | Estradiol 17-beta-dehydrogenase 2 | Oxidoreductase | P37059 |
TCMT689 | TGM2 | Protein-glutamine gamma-glutamyltransferase | Transferase | P21980 |
TCMT709 | SLC28A2 | Sodium/nucleoside cotransporter 2 | Transporter | O43868 |
TCMT710 | SLC28A1 | Sodium/nucleoside cotransporter 1 | Transporter | O00337 |
TCMT752 | CSNK2A1 | Casein kinase II alpha | Kinase | P68400 |
TCMT8 | KDM4E | Lysine-specific demethylase 4D-like | Oxidoreductase | B2RXH2 |
TCMT801 | TUBB3 | Tubulin beta-3 chain | Unclassified | Q13509 |
TCMT808 | FABP5 | Fatty acid binding protein epidermal | Unclassified | Q01469 |
TCMT809 | FABP2 | Fatty acid binding protein intestinal | Unclassified | P12104 |
TCMT810 | TLR2 | Toll-like receptor 2 | Unclassified | O60603 |
TCMT82 | ESR1 | Estrogen receptor alpha | Nuclear receptor | P03372 |
TCMT822 | FUT7 | Alpha-(1,3)-fucosyltransferase 7 | Transferase | Q11130 |
TCMT87 | CYP2C9 | Cytochrome P450 2C9 | Oxidoreductase | P11712 |
TCMT907 | FDPS | Farnesyl diphosphate synthase | Lyase | P14324 |
TCMT910 | ESRRB | Estrogen-related receptor beta | Nuclear receptor | O95718 |
Target ID | Target Name |
---|---|
TCMT1170 | Enterobacter cloacae |
TCMT1175 | Human immunodeficiency virus |
TCMT1176 | Streptococcus pneumoniae |
TCMT1178 | Actinomyces viscosus |
TCMT1179 | Escherichia coli ATCC 8739 |
TCMT1181 | Mycobacterium tuberculosis H37Ra |
TCMT1186 | Plasmodium yoelii yoelii |
TCMT1191 | Bacillus megaterium |
TCMT1206 | Influenza A virus (A/PR/8/34(H1N1)) |
TCMT1209 | Staphylococcus haemolyticus |
TCMT1212 | Verticillium dahliae |
TCMT1214 | Enterococcus faecium |
TCMT1215 | Pseudomonas aeruginosa PAO1 |
TCMT1217 | Bacillus anthracis |
TCMT1218 | Staphylococcus aureus |
TCMT1223 | Staphylococcus epidermidis |
TCMT1224 | Proteus mirabilis |
TCMT1226 | Klebsiella pneumoniae |
TCMT1227 | Streptococcus |
TCMT1229 | Enterococcus faecalis |
TCMT1232 | Pseudomonas aeruginosa |
TCMT1234 | Bacillus coagulans |
TCMT1235 | Clostridium sporogenes |
TCMT1236 | Mycobacterium bovis |
TCMT1237 | Mycobacterium kansasii |
TCMT1238 | Mycobacterium xenopi |
TCMT1239 | Mycobacterium marinum |
TCMT1241 | Human rhinovirus 14 |
TCMT1243 | Aspergillus flavus |
TCMT1246 | Escherichia coli |
TCMT1248 | Hepatitis C virus |
TCMT1249 | Dengue virus 2 |
TCMT1251 | Candida albicans |
TCMT1253 | Penicillium chrysogenum |
TCMT1255 | Human immunodeficiency virus 1 |
TCMT1260 | Streptococcus agalactiae |
TCMT1284 | Penicillium expansum |
TCMT1285 | Human coxsackievirus B3 |
TCMT1286 | Bacillus cereus |
TCMT1294 | Human parainfluenza virus 3 |
TCMT1296 | Influenza A virus H3N2 |
TCMT1319 | Corynebacterium xerosis |
TCMT1322 | Streptococcus mitis |
TCMT1323 | Corynebacterium pseudodiphtheriticum |
TCMT1324 | Corynebacterium diphtheriae |
TCMT1333 | Human rhinovirus 1A |
TCMT1346 | Helicobacter pylori |
TCMT1347 | Human rhinovirus 16 |
TCMT1348 | Human rhinovirus 2 |
TCMT1349 | Helicobacter pylori SS1 |
TCMT1353 | Plasmodium yoelii |
TCMT1361 | Neisseria meningitidis |
TCMT1382 | Plasmodium falciparum (isolate K1 / Thailand) |
TCMT1410 | Listeria monocytogenes |
TCMT1412 | Salmonella typhimurium |
TCMT1438 | Plasmodium falciparum |
TCMT1439 | Mycobacterium smegmatis |
TCMT1442 | Leishmania donovani |
TCMT1443 | Leishmania amazonensis |
TCMT1447 | Respiratory syncytial virus |
TCMT1448 | Enterobacter aerogenes |
TCMT1449 | Influenza A virus |
TCMT1450 | Plasmodium falciparum 3D7 |
TCMT1454 | Bacillus subtilis |
TCMT1455 | Mycobacterium tuberculosis H37Rv |
TCMT1457 | Leishmania major |
TCMT1458 | Filobasidiella neoformans |
TCMT1462 | Streptococcus mutans |
TCMT1463 | Mycobacterium tuberculosis |
TCMT1464 | Hepatitis B virus |
TCMT1465 | Entamoeba histolytica |
GO Term | GO Name | Enriched Genes | Log10 Adjusted P-value |
---|---|---|---|
[BP] GO:0006629 | lipid metabolic process | ACHE, ADORA1, AKR1B1, AKR1B10, ALOX15, ALOX5, CBR1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, ESR1, FABP3, FABP4, FDPS, FUT7, GBA2, HSD11B1, HSD11B2, HSD17B1, HSD17B2, PPARA, PTGS2 | 10.7401 |
[BP] GO:0044281 | small molecule metabolic process | AKR1B1, AKR1B10, ALOX15, ALOX5, AOX1, CA1, CA12, CA2, CA4, CA7, CA9, CBR1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DHFR, FABP3, FDPS, FUT7, GBA2, IDO1, PPARA, PTGS2, TYR, XDH | 10.1326 |
[BP] GO:0055114 | oxidation-reduction process | AKR1B1, AKR1B10, ALOX15, ALOX5, AOX1, CBR1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DHFR, GSK3B, HSD11B1, HSD11B2, HSD17B1, HSD17B2, IDO1, PTGS2, TYR, XDH | 9.76301 |
[BP] GO:0008202 | steroid metabolic process | AKR1B1, AKR1B10, CYP19A1, CYP1A1, CYP1A2, CYP1B1, ESR1, FDPS, GBA2, HSD11B1, HSD11B2, HSD17B1, HSD17B2 | 9.70368 |
[BP] GO:0006730 | one-carbon metabolic process | CA1, CA12, CA2, CA4, CA7, CA9, DHFR | 7.89254 |
[BP] GO:0015701 | bicarbonate transport | CA1, CA12, CA14, CA2, CA4, CA7, CA9 | 7.28353 |
[BP] GO:0033993 | response to lipid | ALPL, BCL2, CA2, CA9, CDK6, CSNK2A1, CYP1A1, CYP1A2, ESR1, ESRRA, FABP3, HSD11B2, HSD17B2, IDO1, PTGS2, TYR | 7.18079 |
[BP] GO:1901700 | response to oxygen-containing compound | AKR1B1, ALPL, BCL2, CA9, CDK6, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DHFR, ESR1, ESRRA, FABP3, GSK3B, HSD11B2, HSD17B2, IDO1, PPARA, PTGS2, TYR | 7.17664 |
[BP] GO:0042445 | hormone metabolic process | ACHE, AKR1B1, CYP19A1, CYP1A1, CYP1B1, ESR1, HSD11B1, HSD11B2, HSD17B1, HSD17B2 | 7.05376 |
[BP] GO:0019748 | secondary metabolic process | AKR1B1, AKR1B10, BCL2, CYP1A1, CYP1A2, CYP1B1, TYR | 6.98565 |
[BP] GO:0008152 | metabolic process | ACHE, ADORA1, AKR1B1, AKR1B10, ALOX15, ALOX5, ALPL, AOX1, BCL2, CA1, CA12, CA2, CA4, CA7, CA9, CBR1, CDC25B, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DHFR, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FDPS, FUT7, GBA2, GSK3B, HSD11B1, HSD11B2, HSD17B1, HSD17B2, IDO1, PPARA, PTGS2, PTPN1, PTPRS, TNKS, TNKS2, TYR, XDH | 6.75774 |
[BP] GO:0010033 | response to organic substance | AKR1B1, ALOX15, ALPL, BCL2, CA2, CA9, CDK6, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DHFR, ESR1, ESRRA, FABP3, FABP4, GSK3B, HSD11B2, HSD17B2, IDO1, PPARA, PTGS2, TYR | 6.39391 |
[BP] GO:0065008 | regulation of biological quality | ABCB1, ACHE, ADORA1, AKR1B1, ALOX15, BCL2, CA12, CA2, CA7, CDK6, CYP19A1, CYP1A1, CYP1B1, DHFR, ESR1, F3, FABP3, FABP4, GSK3B, HSD11B1, HSD11B2, HSD17B1, HSD17B2, PPARA, PTGS2, TNKS, TNKS2, XDH | 5.589 |
[BP] GO:0044255 | cellular lipid metabolic process | ACHE, AKR1B10, ALOX15, ALOX5, CBR1, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, FABP3, FABP4, FDPS, FUT7, GBA2, PPARA, PTGS2 | 5.589 |
[BP] GO:0042221 | response to chemical | ABCB1, AKR1B1, ALOX15, ALPL, BCL2, CA2, CA9, CDK6, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DHFR, ESR1, ESRRA, FABP3, FABP4, GSK3B, HSD11B2, HSD17B2, IDO1, PPARA, PTGS2, TYR | 5.39795 |
[BP] GO:0014070 | response to organic cyclic compound | ALPL, BCL2, CA2, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DHFR, ESR1, ESRRA, HSD11B2, PTGS2, TYR | 5.36626 |
[BP] GO:0019369 | arachidonic acid metabolic process | ALOX15, CBR1, CYP1A1, CYP1A2, CYP1B1, PTGS2 | 5.2396 |
[BP] GO:0033559 | unsaturated fatty acid metabolic process | ALOX15, ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1, PTGS2 | 5.22018 |
[BP] GO:1901615 | organic hydroxy compound metabolic process | AKR1B1, AKR1B10, ALOX15, BCL2, CYP19A1, CYP1A1, CYP1B1, DHFR, FDPS, GBA2, TYR | 5.08656 |
[BP] GO:0044237 | cellular metabolic process | ACHE, AKR1B1, AKR1B10, ALOX15, ALOX5, ALPL, AOX1, BCL2, CA1, CA12, CA2, CA4, CA7, CA9, CBR1, CDC25B, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DHFR, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, FDPS, FUT7, GBA2, GSK3B, HSD17B1, HSD17B2, IDO1, PPARA, PTGS2, PTPN1, PTPRS, TNKS, TNKS2, TYR, XDH | 5.0701 |
[BP] GO:0006690 | icosanoid metabolic process | ALOX15, ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1, PTGS2 | 5.0701 |
[BP] GO:0042446 | hormone biosynthetic process | AKR1B1, CYP19A1, HSD11B1, HSD11B2, HSD17B1, HSD17B2 | 5.01141 |
[BP] GO:0009725 | response to hormone | AKR1B1, ALPL, BCL2, CA2, CA9, CSNK2A1, CYP1A2, ESR1, ESRRA, FABP3, HSD11B2, PPARA, PTGS2 | 5.01141 |
[BP] GO:0034754 | cellular hormone metabolic process | AKR1B1, CYP19A1, CYP1A1, CYP1B1, ESR1, HSD17B1, HSD17B2 | 4.99692 |
[BP] GO:0008610 | lipid biosynthetic process | ACHE, AKR1B1, ALOX15, CSNK2A1, CYP19A1, CYP1A1, FDPS, HSD11B1, HSD11B2, HSD17B1, HSD17B2, PTGS2 | 4.90213 |
[BP] GO:0006694 | steroid biosynthetic process | AKR1B1, CYP19A1, FDPS, HSD11B1, HSD11B2, HSD17B1, HSD17B2 | 4.56953 |
[BP] GO:0032787 | None | ALOX15, ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1, FABP3, GBA2, IDO1, PPARA, PTGS2 | 4.55877 |
[BP] GO:0032847 | regulation of cellular pH reduction | BCL2, CA2, CA7 | 4.38701 |
[BP] GO:0006631 | fatty acid metabolic process | ALOX15, ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1, FABP3, PPARA, PTGS2 | 4.33597 |
[BP] GO:0010817 | regulation of hormone levels | ACHE, ADORA1, AKR1B1, CYP19A1, CYP1A1, CYP1B1, ESR1, HSD11B1, HSD11B2, HSD17B1, HSD17B2 | 4.33597 |
[BP] GO:0032502 | developmental process | ACHE, ADORA1, AKR1B1, ALOX15, ALPL, BCL2, CA2, CA9, CBR1, CDC25B, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DHFR, ESR1, ESRRA, ESRRB, FABP4, FUT7, GBA2, GSK3B, HSD11B1, HSD17B2, PPARA, PTGS2, PTPRS, TNKS2, TYR | 4.29131 |
[BP] GO:0015711 | organic anion transport | ABCB1, CA1, CA12, CA14, CA2, CA4, CA7, CA9, FABP3, PPARA | 4.16251 |
[BP] GO:0048856 | anatomical structure development | ACHE, ADORA1, AKR1B1, ALOX15, ALPL, BCL2, CA2, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DHFR, ESR1, ESRRA, ESRRB, GBA2, GSK3B, HSD11B1, HSD17B2, PPARA, PTGS2, PTPRS, TYR | 4.15748 |
[BP] GO:1901568 | fatty acid derivative metabolic process | ALOX15, ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1, PTGS2 | 4.07651 |
[BP] GO:0009719 | response to endogenous stimulus | AKR1B1, ALPL, BCL2, CA2, CA9, CSNK2A1, CYP1A2, ESR1, ESRRA, FABP3, GSK3B, HSD11B2, PPARA, PTGS2 | 4.04033 |
[BP] GO:0001676 | long-chain fatty acid metabolic process | ALOX15, CBR1, CYP1A1, CYP1A2, CYP1B1, PTGS2 | 3.94256 |
[BP] GO:0019752 | carboxylic acid metabolic process | ALOX15, ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1, DHFR, FABP3, GBA2, IDO1, PPARA, PTGS2, TYR | 3.89421 |
[BP] GO:0048513 | animal organ development | ACHE, BCL2, CA2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, ESR1, ESRRA, ESRRB, HSD11B1, HSD17B2, PPARA, PTPRS, TYR | 3.88333 |
[BP] GO:0044238 | primary metabolic process | ACHE, ADORA1, AKR1B1, AKR1B10, ALOX15, ALOX5, ALPL, AOX1, BCL2, CBR1, CDC25B, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DHFR, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FDPS, FUT7, GBA2, GSK3B, HSD11B1, HSD11B2, HSD17B1, HSD17B2, IDO1, PPARA, PTGS2, PTPN1, PTPRS, TNKS, TNKS2, TYR, XDH | 3.84418 |
[BP] GO:0008210 | estrogen metabolic process | CYP19A1, CYP1B1, HSD17B1, HSD17B2 | 3.7546 |
[BP] GO:0009611 | response to wounding | ACHE, ADORA3, ALOX15, BCL2, CYP1A1, DHFR, PPARA | 3.74899 |
[BP] GO:0016042 | lipid catabolic process | ADORA1, AKR1B10, CYP19A1, CYP1A2, CYP1B1, FABP3, FABP4, GBA2 | 3.6905 |
[BP] GO:0043436 | oxoacid metabolic process | ALOX15, ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1, DHFR, FABP3, GBA2, IDO1, PPARA, PTGS2, TYR | 3.50518 |
[BP] GO:0006082 | organic acid metabolic process | ALOX15, ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1, DHFR, FABP3, GBA2, IDO1, PPARA, PTGS2, TYR | 3.43805 |
[BP] GO:0017144 | drug metabolic process | ACHE, AKR1B1, AKR1B10, AOX1, CBR1, CYP1A1, CYP1A2, CYP1B1, DHFR, IDO1 | 3.43805 |
[BP] GO:0006820 | anion transport | ABCB1, CA1, CA12, CA14, CA2, CA4, CA7, CA9, FABP3, PPARA | 3.326 |
[BP] GO:0071704 | organic substance metabolic process | ACHE, ADORA1, AKR1B1, AKR1B10, ALOX15, ALOX5, ALPL, AOX1, BCL2, CBR1, CDC25B, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DHFR, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FDPS, FUT7, GBA2, GSK3B, HSD11B1, HSD11B2, HSD17B1, HSD17B2, IDO1, PPARA, PTGS2, PTPN1, PTPRS, TNKS, TNKS2, TYR, XDH | 3.25058 |
[BP] GO:2001225 | regulation of chloride transport | ABCB1, CA2, CA7 | 3.21588 |
[BP] GO:0097267 | omega-hydroxylase P450 pathway | CYP1A1, CYP1A2, CYP1B1 | 3.21588 |
[BP] GO:0044283 | None | AKR1B1, ALOX15, ALOX5, CYP19A1, CYP1A1, DHFR, FDPS, IDO1, PTGS2 | 3.19681 |
[BP] GO:0042493 | response to drug | ABCB1, AKR1B1, BCL2, CA9, CDK6, CYP1A1, CYP1B1, DHFR, FABP3, HSD11B2, PTGS2 | 3.04022 |
[BP] GO:0010035 | response to inorganic substance | AKR1B1, ALOX15, BCL2, CA2, CYP1A1, CYP1A2, CYP1B1, FABP4, PTGS2 | 3.02654 |
[BP] GO:0010647 | positive regulation of cell communication | ADORA1, AKR1B1, ALOX15, BCL2, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, F3, GSK3B, PTGS2, PTPN1, TNKS, TNKS2, XDH | 2.98105 |
[BP] GO:0023056 | positive regulation of signaling | ADORA1, AKR1B1, ALOX15, BCL2, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, F3, GSK3B, PTGS2, PTPN1, TNKS, TNKS2, XDH | 2.96243 |
[BP] GO:0080134 | regulation of response to stress | ABCB1, ADORA1, CDK6, CYP19A1, DHFR, ESR1, F3, FABP4, GSK3B, IDO1, PPARA, PTGS2, PTPN1, PTPRS, XDH | 2.93392 |
[BP] GO:1901617 | organic hydroxy compound biosynthetic process | AKR1B1, ALOX15, CYP19A1, DHFR, FDPS, TYR | 2.93006 |
[BP] GO:0022900 | electron transport chain | AKR1B1, AOX1, CYP19A1, CYP1A2, IDO1, XDH | 2.93006 |
[BP] GO:0006703 | estrogen biosynthetic process | CYP19A1, HSD17B1, HSD17B2 | 2.89357 |
[BP] GO:0009115 | None | AOX1, XDH | 2.78341 |
[BP] GO:1901575 | None | ACHE, ADORA1, AKR1B10, AOX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, FABP3, FABP4, FUT7, GBA2, GSK3B, IDO1, XDH | 2.66031 |
[BP] GO:0006721 | terpenoid metabolic process | AKR1B10, CYP1A1, CYP1A2, CYP1B1, FDPS | 2.64651 |
[BP] GO:0019372 | lipoxygenase pathway | ALOX15, ALOX5, PTGS2 | 2.64651 |
[BP] GO:0016137 | None | AKR1B1, AKR1B10, GBA2 | 2.49353 |
[BP] GO:0009056 | catabolic process | ACHE, ADORA1, AKR1B10, AOX1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, FABP3, FABP4, FUT7, GBA2, GSK3B, IDO1, XDH | 2.46633 |
[BP] GO:0042127 | regulation of cell proliferation | ADORA1, ADORA3, AKR1B1, BCL2, CDC25B, CDK6, CSNK2A1, CYP1B1, ESR1, ESRRA, F3, FABP3, IDO1, PTGS2, XDH | 2.42597 |
[BP] GO:0048518 | positive regulation of biological process | ABCB1, ACHE, ADORA1, AKR1B1, ALOX15, BCL2, CA2, CA7, CDC25B, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, DHFR, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, GSK3B, IDO1, PPARA, PTGS2, PTPN1, TNKS, TNKS2, XDH | 2.35886 |
[BP] GO:0046110 | None | AOX1, XDH | 2.35824 |
[BP] GO:0032849 | positive regulation of cellular pH reduction | CA2, CA7 | 2.35824 |
[BP] GO:0006720 | isoprenoid metabolic process | AKR1B10, CYP1A1, CYP1A2, CYP1B1, FDPS | 2.35824 |
[BP] GO:0010038 | response to metal ion | ALOX15, BCL2, CA2, CYP1A1, CYP1A2, FABP4, PTGS2 | 2.34533 |
[BP] GO:0019373 | epoxygenase P450 pathway | CYP1A1, CYP1A2, CYP1B1 | 2.32163 |
[BP] GO:0043401 | steroid hormone mediated signaling pathway | ESR1, ESR2, ESRRA, ESRRB, PPARA | 2.28823 |
[BP] GO:0050896 | response to stimulus | ABCB1, ACHE, ADORA1, ADORA3, AKR1B1, ALOX15, ALPL, BCL2, CA2, CA9, CDK6, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DHFR, ESR1, ESRRA, F3, FABP3, FABP4, GSK3B, HSD11B2, HSD17B2, IDO1, PPARA, PTGS2, PTPN1, TYR | 2.2456 |
[BP] GO:0006091 | generation of precursor metabolites and energy | AKR1B1, AOX1, CYP19A1, CYP1A2, GSK3B, IDO1, XDH | 2.21708 |
[BP] GO:0009404 | toxin metabolic process | CYP1A1, CYP1A2, CYP1B1 | 2.21471 |
[BP] GO:0042180 | None | AKR1B1, AKR1B10, CYP19A1, IDO1 | 2.16526 |
[BP] GO:1903409 | reactive oxygen species biosynthetic process | CYP1A1, CYP1A2, CYP1B1 | 2.16523 |
[BP] GO:0032844 | regulation of homeostatic process | ADORA1, BCL2, CA2, CA7, CDK6, PTGS2, TNKS, TNKS2 | 2.15822 |
[BP] GO:0070213 | None | TNKS, TNKS2 | 2.10918 |
[BP] GO:0006145 | None | AOX1, XDH | 2.10918 |
[BP] GO:0018894 | dibenzo-p-dioxin metabolic process | CYP1A1, CYP1A2 | 2.10918 |
[BP] GO:0071248 | cellular response to metal ion | ALOX15, CYP1A1, CYP1A2, FABP4, PTGS2 | 2.06007 |
[BP] GO:0031214 | biomineral tissue development | ALOX15, ALPL, PPARA, PTGS2 | 2.05217 |
[BP] GO:0048583 | regulation of response to stimulus | ABCB1, ADORA1, AKR1B1, ALOX15, BCL2, CDK6, CSNK2A1, CYP19A1, CYP1B1, DHFR, ESR1, ESR2, ESRRA, F3, FABP4, GSK3B, IDO1, PPARA, PTGS2, PTPN1, PTPRS, TNKS, TNKS2, XDH | 2.05077 |
[CC] GO:0044444 | cytoplasmic part | ACHE, ADORA1, AKR1B1, AKR1B10, ALOX15, ALOX5, AOX1, BCL2, CA1, CA2, CA4, CA7, CBR1, CDC25B, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DHFR, ESR1, ESR2, FABP3, FABP4, FDPS, FUT7, GBA2, GSK3B, HSD11B1, HSD11B2, HSD17B1, HSD17B2, IDO1, PTGS2, PTPN1, PTPRS, TNKS, TNKS2, TYR, XDH | 2.63305 |
[CC] GO:0005789 | endoplasmic reticulum membrane | BCL2, CYP19A1, CYP1A1, CYP1A2, CYP1B1, GBA2, HSD11B1, HSD11B2, HSD17B2, PTGS2 | 1.69864 |
[CC] GO:0099055 | None | ADORA1, PTPRS | 1.52404 |
[CC] GO:0099699 | None | ADORA1, PTPRS | 1.52404 |
[CC] GO:0099240 | None | ADORA1, PTPRS | 1.52404 |
[MF] GO:0004089 | carbonate dehydratase activity | CA1, CA12, CA14, CA2, CA4, CA7, CA9 | 10.3337 |
[MF] GO:0046914 | transition metal ion binding | ALOX15, ALOX5, AOX1, CA1, CA12, CA2, CA4, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, ESR1, ESR2, ESRRA, ESRRB, PPARA, PTPN1, TNKS, TYR, XDH | 10.1849 |
[MF] GO:0003824 | catalytic activity | ABCB1, ACHE, ADORA1, AKR1B1, AKR1B10, ALOX15, ALOX5, ALPL, AOX1, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CBR1, CDC25B, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DHFR, F3, FDPS, FUT7, GBA2, GSK3B, HSD11B1, HSD11B2, HSD17B1, HSD17B2, IDO1, PTGS2, PTPN1, PTPRS, TNKS, TNKS2, TUBB3, TYR, XDH | 10.1849 |
[MF] GO:0016491 | oxidoreductase activity | AKR1B1, AKR1B10, ALOX15, ALOX5, AOX1, CBR1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DHFR, HSD11B1, HSD11B2, HSD17B1, HSD17B2, IDO1, PTGS2, TYR, XDH | 10.1326 |
[MF] GO:0043167 | ion binding | ABCB1, ACHE, ALOX15, ALOX5, ALPL, AOX1, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DHFR, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FDPS, GSK3B, HSD17B1, IDO1, PPARA, PTGS2, PTPN1, PTPRS, TNKS, TNKS2, TUBB3, TYR, XDH | 7.25774 |
[MF] GO:0016614 | oxidoreductase activity, acting on CH-OH group of donors | AKR1B1, AKR1B10, AOX1, CBR1, HSD11B1, HSD11B2, HSD17B1, HSD17B2, XDH | 6.8993 |
[MF] GO:0016836 | hydro-lyase activity | CA1, CA12, CA14, CA2, CA4, CA7, CA9 | 6.79983 |
[MF] GO:0016835 | carbon-oxygen lyase activity | CA1, CA12, CA14, CA2, CA4, CA7, CA9 | 5.89777 |
[MF] GO:0005506 | iron ion binding | ALOX15, ALOX5, AOX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, XDH | 5.08656 |
[MF] GO:0016616 | oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor | AKR1B1, AKR1B10, CBR1, HSD11B1, HSD11B2, HSD17B1, HSD17B2 | 4.72926 |
[MF] GO:0048037 | cofactor binding | AOX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DHFR, HSD11B2, HSD17B1, IDO1, PTGS2, XDH | 4.53365 |
[MF] GO:0043169 | cation binding | ACHE, ALOX15, ALOX5, ALPL, AOX1, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, ESR1, ESR2, ESRRA, ESRRB, FDPS, IDO1, PPARA, PTGS2, PTPN1, TNKS, TNKS2, TYR, XDH | 4.29131 |
[MF] GO:0005496 | steroid binding | ESR1, ESR2, ESRRA, ESRRB, HSD11B2, HSD17B1 | 4.25336 |
[MF] GO:0008270 | zinc ion binding | CA1, CA12, CA2, CA4, CA7, CA9, ESR1, ESR2, ESRRA, ESRRB, PPARA, PTPN1, TNKS | 4.11974 |
[MF] GO:0098531 | transcription factor activity, direct ligand regulated sequence-specific DNA binding | ESR1, ESR2, ESRRA, ESRRB, PPARA | 4.05485 |
[MF] GO:0004879 | nuclear receptor activity | ESR1, ESR2, ESRRA, ESRRB, PPARA | 4.05485 |
[MF] GO:0046872 | metal ion binding | ALOX15, ALOX5, ALPL, AOX1, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, ESR1, ESR2, ESRRA, ESRRB, FDPS, IDO1, PPARA, PTGS2, PTPN1, TNKS, TNKS2, TYR, XDH | 3.94578 |
[MF] GO:0070330 | aromatase activity | CYP19A1, CYP1A1, CYP1A2, CYP1B1 | 3.81794 |
[MF] GO:0009055 | electron transfer activity | AKR1B1, AOX1, CYP19A1, CYP1A2, IDO1, XDH | 3.78327 |
[MF] GO:0003707 | steroid hormone receptor activity | ESR1, ESR2, ESRRA, ESRRB, PPARA | 3.73082 |
[MF] GO:0016829 | lyase activity | CA1, CA12, CA14, CA2, CA4, CA7, CA9 | 3.68945 |
[MF] GO:0016712 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen | CYP19A1, CYP1A1, CYP1A2, CYP1B1 | 3.65012 |
[MF] GO:0016702 | oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen | ALOX15, ALOX5, IDO1, PTGS2 | 3.65012 |
[MF] GO:0033764 | steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor | HSD11B1, HSD11B2, HSD17B1, HSD17B2 | 3.59451 |
[MF] GO:0016701 | oxidoreductase activity, acting on single donors with incorporation of molecular oxygen | ALOX15, ALOX5, IDO1, PTGS2 | 3.59451 |
[MF] GO:0016229 | steroid dehydrogenase activity | HSD11B1, HSD11B2, HSD17B1, HSD17B2 | 3.4776 |
[MF] GO:0020037 | heme binding | CYP19A1, CYP1A1, CYP1A2, CYP1B1, IDO1, PTGS2 | 3.43805 |
[MF] GO:0008289 | lipid binding | ALOX15, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, HSD11B2, HSD17B1, PPARA | 3.35707 |
[MF] GO:0046906 | tetrapyrrole binding | CYP19A1, CYP1A1, CYP1A2, CYP1B1, IDO1, PTGS2 | 3.26928 |
[MF] GO:0016705 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen | CYP19A1, CYP1A1, CYP1A2, CYP1B1, PTGS2, TYR | 3.0151 |
[MF] GO:0004497 | monooxygenase activity | CYP19A1, CYP1A1, CYP1A2, CYP1B1, TYR | 2.86313 |
[MF] GO:0016903 | None | AKR1B1, AKR1B10, AOX1, XDH | 2.84888 |
[MF] GO:0019825 | oxygen binding | CYP19A1, CYP1A1, CYP1A2, CYP1B1 | 2.81412 |
[MF] GO:0038052 | RNA polymerase II transcription factor activity, estrogen-activated sequence-specific DNA binding | ESR1, ESR2 | 2.78341 |
[MF] GO:0003845 | None | HSD11B1, HSD11B2 | 2.78341 |
[MF] GO:0050473 | arachidonate 15-lipoxygenase activity | ALOX15, PTGS2 | 2.35824 |
[MF] GO:0034056 | estrogen response element binding | ESR1, ESR2 | 2.10918 |
KEGG Pathway ID | Enriched Genes | Log10 Adjusted P-value |
---|---|---|
Metabolic pathways_Homo sapiens_hsa01100 | FDPS, CBR1, ALOX15, AKR1B1, PTGS2, TYR, GBA2, CYP19A1, DHFR, HSD11B1, FUT7, AKR1B10, ALOX5, HSD17B1, HSD17B2, CYP1A2, CYP1A1, AOX1, ALPL, XDH, IDO1 | 10.1812 |
Nitrogen metabolism_Homo sapiens_hsa00910 | CA12, CA1, CA2, CA4, CA7, CA9, CA14 | 11.9183 |
Steroid hormone biosynthesis_Homo sapiens_hsa00140 | HSD11B1, HSD11B2, HSD17B1, HSD17B2, CYP1A2, CYP1A1, CYP1B1, CYP19A1 | 10.0835 |
Ovarian steroidogenesis_Homo sapiens_hsa04913 | ALOX5, HSD17B1, HSD17B2, CYP1A1, CYP1B1, PTGS2, CYP19A1 | 8.838 |
Tryptophan metabolism_Homo sapiens_hsa00380 | CYP1A2, CYP1A1, AOX1, CYP1B1, IDO1 | 5.8595 |
Chemical carcinogenesis_Homo sapiens_hsa05204 | HSD11B1, CBR1, CYP1A2, CYP1A1, CYP1B1, PTGS2 | 5.8595 |
Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | HSD11B1, CBR1, CYP1A2, CYP1A1, CYP1B1 | 4.658 |
Arachidonic acid metabolism_Homo sapiens_hsa00590 | CBR1, ALOX5, ALOX15, PTGS2 | 3.517 |
MicroRNAs in cancer_Homo sapiens_hsa05206 | CDK6, ABCB1, BCL2, CYP1B1, PTGS2, CDC25B | 2.8529 |
Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | FABP4, ADORA1, PTGS2 | 2.3422 |
Prolactin signaling pathway_Homo sapiens_hsa04917 | GSK3B, ESR1, ESR2 | 2.1568 |
Retinol metabolism_Homo sapiens_hsa00830 | CYP1A2, CYP1A1, AOX1 | 2.2244 |
Small cell lung cancer_Homo sapiens_hsa05222 | CDK6, BCL2, PTGS2 | 1.9614 |
PPAR signaling pathway_Homo sapiens_hsa03320 | FABP3, FABP4, PPARA | 2.1807 |
NF-kappa B signaling pathway_Homo sapiens_hsa04064 | CSNK2A1, BCL2, PTGS2 | 1.9151 |
Insulin resistance_Homo sapiens_hsa04931 | PTPN1, GSK3B, PPARA | 1.7873 |
Serotonergic synapse_Homo sapiens_hsa04726 | ALOX5, ALOX15, PTGS2 | 1.7873 |
Sphingolipid signaling pathway_Homo sapiens_hsa04071 | ADORA3, BCL2, ADORA1 | 1.7438 |
Measles_Homo sapiens_hsa05162 | GSK3B, CDK6, CSNK2A1 | 1.6413 |
Cell cycle_Homo sapiens_hsa04110 | GSK3B, CDK6, CDC25B | 1.7373 |
Epstein-Barr virus infection_Homo sapiens_hsa05169 | GSK3B, CSNK2A1, BCL2 | 1.2637 |
Pathways in cancer_Homo sapiens_hsa05200 | GSK3B, CDK6, BCL2, PTGS2 | 1.1852 |
Colorectal cancer_Homo sapiens_hsa05210 | GSK3B, BCL2 | 1.3429 |
Glycerolipid metabolism_Homo sapiens_hsa00561 | AKR1B10, AKR1B1 | 1.3696 |
Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | CYP1A2, AOX1 | 1.2686 |
Prostate cancer_Homo sapiens_hsa05215 | GSK3B, BCL2 | 1.1372 |
AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | BCL2, F3 | 1.0692 |
Linoleic acid metabolism_Homo sapiens_hsa00591 | ALOX15, CYP1A2 | 1.7891 |
Galactose metabolism_Homo sapiens_hsa00052 | AKR1B10, AKR1B1 | 1.7873 |
Estrogen signaling pathway_Homo sapiens_hsa04915 | ESR1, ESR2 | 1.0692 |
Cholinergic synapse_Homo sapiens_hsa04725 | ACHE, BCL2 | 1.0046 |
Melanogenesis_Homo sapiens_hsa04916 | GSK3B, TYR | 1.0692 |
Bile secretion_Homo sapiens_hsa04976 | ABCB1, CA2 | 1.2637 |
Adherens junction_Homo sapiens_hsa04520 | PTPN1, CSNK2A1 | 1.2637 |
Tyrosine metabolism_Homo sapiens_hsa00350 | AOX1, TYR | 1.7438 |
Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | CA2, CA4 | 1.942 |
Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | GSK3B, ESR1 | 0.9767 |
Toxoplasmosis_Homo sapiens_hsa05145 | ALOX5, BCL2 | 0.9767 |
Neurotrophin signaling pathway_Homo sapiens_hsa04722 | GSK3B, BCL2 | 0.9735 |
Hepatitis C_Homo sapiens_hsa05160 | GSK3B, PPARA | 0.9126 |
PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | GSK3B, CDK6, BCL2 | 0.8834 |
Hepatitis B_Homo sapiens_hsa05161 | CDK6, BCL2 | 0.8911 |
Insulin signaling pathway_Homo sapiens_hsa04910 | PTPN1, GSK3B | 0.8979 |
Wnt signaling pathway_Homo sapiens_hsa04310 | GSK3B, CSNK2A1 | 0.8979 |
Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | GSK3B, ESRRB | 0.8979 |
Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | GSK3B, PPARA | 0.8834 |
Fructose and mannose metabolism_Homo sapiens_hsa00051 | AKR1B10, AKR1B1 | 1.7873 |
Jak-STAT signaling pathway_Homo sapiens_hsa04630 | BCL2, AOX1 | 0.8576 |
Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | AKR1B10, AKR1B1 | 1.7395 |
cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | ADORA3, ADORA1 | 0.8386 |
Influenza A_Homo sapiens_hsa05164 | FDPS, GSK3B | 0.8184 |
cAMP signaling pathway_Homo sapiens_hsa04024 | ADORA1, PPARA | 0.7469 |
Focal adhesion_Homo sapiens_hsa04510 | GSK3B, BCL2 | 0.7469 |
Folate biosynthesis_Homo sapiens_hsa00790 | DHFR, ALPL | 2.2281 |
HTLV-I infection_Homo sapiens_hsa05166 | FDPS, GSK3B | 0.6465 |
Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | ADORA3, ADORA1 | 0.6264 |
MAPK signaling pathway_Homo sapiens_hsa04010 | CDC25B | 0.3122 |
Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | BCL2 | 0.421 |
Viral carcinogenesis_Homo sapiens_hsa05203 | CDK6 | 0.3781 |
Purine metabolism_Homo sapiens_hsa00230 | XDH | 0.4108 |
Proteoglycans in cancer_Homo sapiens_hsa05205 | ESR1 | 0.3781 |
Apoptosis_Homo sapiens_hsa04210 | BCL2 | 0.4641 |
Herpes simplex infection_Homo sapiens_hsa05168 | CSNK2A1 | 0.4015 |
Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | BCL2 | 0.4481 |
Tight junction_Homo sapiens_hsa04530 | CSNK2A1 | 0.4641 |
Hippo signaling pathway_Homo sapiens_hsa04390 | GSK3B | 0.4419 |
Tuberculosis_Homo sapiens_hsa05152 | BCL2 | 0.4108 |
Alzheimer's disease_Homo sapiens_hsa05010 | GSK3B | 0.421 |
Oxytocin signaling pathway_Homo sapiens_hsa04921 | PTGS2 | 0.4369 |
Phagosome_Homo sapiens_hsa04145 | TUBB3 | 0.4419 |
Chemokine signaling pathway_Homo sapiens_hsa04062 | GSK3B | 0.4015 |
Axon guidance_Homo sapiens_hsa04360 | GSK3B | 0.4872 |
Dopaminergic synapse_Homo sapiens_hsa04728 | GSK3B | 0.4856 |
Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | CDC25B | 0.5586 |
TNF signaling pathway_Homo sapiens_hsa04668 | PTGS2 | 0.5364 |
Glucagon signaling pathway_Homo sapiens_hsa04922 | PPARA | 0.5558 |
HIF-1 signaling pathway_Homo sapiens_hsa04066 | BCL2 | 0.5533 |
ErbB signaling pathway_Homo sapiens_hsa04012 | GSK3B | 0.5776 |
T cell receptor signaling pathway_Homo sapiens_hsa04660 | GSK3B | 0.5533 |
Glycerophospholipid metabolism_Homo sapiens_hsa00564 | ACHE | 0.5619 |
Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | PTGS2 | 0.5558 |
Morphine addiction_Homo sapiens_hsa05032 | ADORA1 | 0.5735 |
Pancreatic secretion_Homo sapiens_hsa04972 | CA2 | 0.5619 |
Gap junction_Homo sapiens_hsa04540 | TUBB3 | 0.5776 |
Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | CSNK2A1 | 0.5776 |
B cell receptor signaling pathway_Homo sapiens_hsa04662 | GSK3B | 0.6264 |
Chronic myeloid leukemia_Homo sapiens_hsa05220 | CDK6 | 0.6264 |
Melanoma_Homo sapiens_hsa05218 | CDK6 | 0.6264 |
Peroxisome_Homo sapiens_hsa04146 | XDH | 0.5906 |
Adipocytokine signaling pathway_Homo sapiens_hsa04920 | PPARA | 0.6264 |
Pancreatic cancer_Homo sapiens_hsa05212 | CDK6 | 0.6304 |
Gastric acid secretion_Homo sapiens_hsa04971 | CA2 | 0.6258 |
Glioma_Homo sapiens_hsa05214 | CDK6 | 0.631 |
Leishmaniasis_Homo sapiens_hsa05140 | PTGS2 | 0.6264 |
VEGF signaling pathway_Homo sapiens_hsa04370 | PTGS2 | 0.6455 |
Complement and coagulation cascades_Homo sapiens_hsa04610 | F3 | 0.605 |
Renin secretion_Homo sapiens_hsa04924 | ADORA1 | 0.6317 |
p53 signaling pathway_Homo sapiens_hsa04115 | CDK6 | 0.6264 |
Non-small cell lung cancer_Homo sapiens_hsa05223 | CDK6 | 0.6686 |
Endometrial cancer_Homo sapiens_hsa05213 | GSK3B | 0.6811 |
Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | TUBB3 | 0.6702 |
Basal cell carcinoma_Homo sapiens_hsa05217 | GSK3B | 0.6702 |
Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | BCL2 | 0.683 |
Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | ESR1 | 0.6979 |
Hedgehog signaling pathway_Homo sapiens_hsa04340 | GSK3B | 0.6851 |
Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | AOX1 | 0.6955 |
Drug metabolism - other enzymes_Homo sapiens_hsa00983 | XDH | 0.6979 |
Sphingolipid metabolism_Homo sapiens_hsa00600 | GBA2 | 0.6979 |
Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | HSD11B2 | 0.7469 |
ABC transporters_Homo sapiens_hsa02010 | ABCB1 | 0.7055 |
Caffeine metabolism_Homo sapiens_hsa00232 | CYP1A2, XDH | 3.0557 |
African trypanosomiasis_Homo sapiens_hsa05143 | IDO1 | 0.7729 |
Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | FUT7 | 0.8164 |
Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | AOX1 | 0.8297 |
Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | FUT7 | 0.8529 |
Collecting duct acid secretion_Homo sapiens_hsa04966 | CA2 | 0.8447 |
One carbon pool by folate_Homo sapiens_hsa00670 | DHFR | 0.8979 |
Other glycan degradation_Homo sapiens_hsa00511 | GBA2 | 0.9133 |
Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | FDPS | 0.8911 |
Vitamin B6 metabolism_Homo sapiens_hsa00750 | AOX1 | 1.2637 |